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Abstract 
Background: One of the most important ingredients of felicitous conversation exchanges is the adequate expres‑
sion of illocutionary force and the achievement of perlocutionary effects, which can be considered essential to the 
functioning of pragmatic competence.
Findings: The breakdown of illocutionary and perlocutionary functions is one of the most prominent external 
features of cognitive impairment in Alzheimer’s Disease, with devastating psychological and social consequences for 
patients, their family and caregivers.
Conclusions: The study of pragmatic functions is essential for a proper understanding of the linguistic and commu‑
nicative aspects of Alzheimer’s disease.
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Background
The inception of and most significant developments in 
pragmatic theory during the last century were firmly 
grounded in philosophical and linguistic pursuits. The 
study of linguistic utterances and their association with 
the speaker and addressee’s intentions, plans and beliefs 
has made significant contributions to contemporary 
philosophy of language and linguistic pragmatics. More 
recently, cognitive and social concerns have been brought 
to the fore with the goal of addressing the underlying psy-
chological and social motivations explaining linguistic 
behavior and also the consequences of such behavior in 
these domains. The development of experimental prag-
matics has also increased the connection with empirical 
research and scientific methodologies. This expansion of 
the field is leading to a reconceptualization of the basic 
concepts and hypotheses of pragmatic theory.
In the cognitive realm, the study of pragmatic compe-
tence and its evolution over the life span brings to the fore 
important issues such as the determination of how prag-
matic components are acquired and how they decay; if 
they do so in a consistent sequence and the implications of 
such a sequence, etc. The study of dementia, and the sev-
eral variants of Alzheimer’s Disease (AD), may constitute 
a privileged field to test the decay or preservation of prag-
matic competence (Wray 2015a, b). It is also an ideal test-
ing ground to witness the interplay of linguistic behavior 
with other interactional components in a more general 
cognitive and social environment, since dementia not 
only significantly affects the patients’ cognitive and prag-
matic abilities but also has measurable effects on their 
relatives and other individuals socially or professionally 
involved with them. We argue for a reconceptualization 
of the landscape of cognitive decline and preservation in 
dementia that reinforces the validity of pragmatic theory 
as an important component of a general model of the cog-
nitive and social dynamics underlying this disease.
Models of global cognitive and linguistic decline
The literature on Alzheimer’s Disease (AD) emphasizes 
the centrality of progressive deficits in memory and other 
aspects of cognition as the key diagnostic criterion of the 
disease (DSM-IV-TR, American Psychiatric Association 
2000; Reisberg et al. 1982; Helkala et al. 1988). In an effort 
to conceptualize how progressive impairment proceeds 
in the illness, cognitive impairment is a central feature 
of academic models of such disease. For example, Geld-
macher’s (2012:130) model of impairment in AD refers to 
“domains of cognitive impairment”. In this model, “mem-
ory” is conceptualized as deficits in learning, semantic 
knowledge failure, repetitiveness; “executive functioning” 
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is viewed as poor planning, poor judgment, impairment 
on complex tasks, disinhibition; “orientation” is under-
stood in terms of distorted time sense, “praxis” is defined 
as ideomotor apraxia, limb-kenetic apraxia; “visual pro-
cessing” as poor object or person recognition, spatial 
confusion, impaired directed attention. The definition of 
“language impairment” is restricted to anomia and diffi-
cult word-finding, poor speech content, impaired pros-
ody (Geldmacher 2012:130). A diagnosis of AD requires 
memory impairment and impairment in at least one 
other “cognitive domain” (Geldmacher 2012:129). Such 
models are based on the idea that deficits resulting from 
synaptic dysfunction and neuronal loss follow a pre-
dictable distribution in the brain (Arab et  al. 2011) and 
will result in the total global cognitive decline and total 
dependence of the AD patient on others.
Language and language decline is sometimes discussed 
as a discrete, separate capacity of AD decline but it too 
has been generally treated in global terms as a model of 
predicting eventual total language impairment (Grand 
et  al. 2011). For example, Blair et  al. (2007:241) argue 
that at early Alzheimer’s, word finding difficulty and cir-
cumlocution in conversation are present. Yet, speech 
deteriorates with disease progression becoming “verbose 
and circuitous…empty and lacking meaningful content” 
(Appell et al. 1982). Vocabulary decreases and irrelevan-
cies increase. It becomes difficult to maintain a topic 
(Mentis et al. 1995). Ultimately, progressive aphasia leads 
to eventual mutism.
There is also a small literature focusing exclusively on 
the linguistic aspects of decline in AD and its effect on 
social interaction. Nevertheless, this literature also posits 
a uni-linear model of global linguistic decline. Accord-
ing to Wray (2015b), language processing is undermined 
by damage to the language areas of the brain. NLP fea-
tures (lexicon, syntax errors) are evident in the natural 
speech of even early Alzheimer’s patients, as AD per-
sons produce syntactically poorer sentences, mention 
lesser number of ideas and words, produce redundant, 
less precise and informative discourse; there is also rare 
use of the modalizers, and pronouns miss their intended 
reference, which implies a loss of the semantic cohe-
sion (Boyé et  al. 2014:4). The progressive loss of ability 
to communicate begins with early AD language deficits 
(word substitutions, aborted phrases), then progresses to 
comprehension deficits, paraphasic errors, and seman-
tic jargon in mid-to-late stage Alzheimer (Tappen et  al. 
2002:63). Semantic and lexical speech features are mul-
tiple and include stutters, self-corrections, incomplete 
sentences, a greater number of empty pauses and lesser 
number of non-empty pauses or a very high percentage 
of personal pronouns (Boyé et al. 2014). Speech becomes 
formulaic and the patient might produce appropriate 
utterances even when there is doubt about whether they 
are really meant (Wray 2013; Hamilton 1994).
Ultimately, the effect of this loss of linguistic functions 
has significant social and pragmatic effects; more specifi-
cally, social isolation from other speakers. This negative 
spiral downward is interactive. As language becomes 
compromised by “short term memory loss, distortions 
in perception, disturbed semantic representation and 
disorientation brought on by lost contextual informa-
tion”, linguistic behavior changes (Wray 2015b). People 
with [early to mid-stage AD] will apply “their remaining 
linguistic and communicative resources to rescue the 
situation, developing strategies for avoiding, compensat-
ing for, and covering up their problems”. Nevertheless, as 
a result of “loss of confidence, depression, altered power 
relationships, the social construction of AD as an illness, 
and the discourse contexts in which people with AD find 
themselves, such as how carers speak to them” (Wray 
2015b), declines may be exaggerated due to the individ-
ual’s awareness of the problem and resultant frustration, 
embarrassment, or anxiety, “leading to further with-
drawal” (Cohen 1991).
This, in turn, often provokes a negative reaction in 
caregivers who, in responding to the AD patient’s com-
municative difficulties, feel discomfort which can then 
inhibit their attempts to communicate with the patient 
which further reduces opportunities for the AD suf-
ferer’s meaningful interaction (Hendryx-Bedalov 1999). 
Comprehension problems and their attempted resolu-
tion become products of social interaction and reflect 
pragmatic impairment (Perkins 2007). According to Tap-
pen et al. (2002:63): “One of the most tragic symptoms of 
Alzheimer’s disease (AD) is the progressive loss of ability 
to communicate”. This loss has obvious adverse conse-
quences for the older individual and their loved ones. For 
the person with AD, sequelae include “isolation, depres-
sion, disturbed behavior, and decreased quality of life” 
(Zanetti et al. 1998). Caregiver stress due to low levels of 
real communication with the patient is endemic (Wray 
2014). The reduction in the AD patient’s capacity for 
empathic concern (other-centered emotional responses) 
can also have a negative effect on caregivers and marital 
relationships especially in later stages of the disease (de 
Vugt et al. 2003).
Thus, previous models of the decline of cognitive and 
specifically linguistic capacities in the disease course of 
AD have all posited a global model of decline as deficits 
in each of these areas progress to the endpoint of total 
cognitive decline and mutism. Untreated AD is, as Schi-
oth et  al. (2012:7) note, a “devastating disease”. In this 
article we advocate a model that focuses on pragmatic 
competence and the loss and re-gaining of cognitive/
pragmatic functions.
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Performatives and pragmatic function
One of the landmarks in the emergence of pragmatic 
theory, as we know it today, is Austin’s (1962) proposal 
on certain sentences, which he called performatives. 
They contrast with other sentences in that a performa-
tive utterance (the utterance of a linguistic performative 
expression) is associated to or intrinsically constitutes 
the performance of an action. There are three acts 
related to an utterance and Austin suggests that a 
speaker can simultaneously perform three acts in issu-
ing an utterance: the locutionary act is the act of say-
ing something meaningful (to which a truth value can 
be ascribed); the illocutionary act is the act performed 
in saying something, essentially the performative utter-
ance (the act identified by an explicit performative verb); 
and the perlocutionary act or effect, which is the act per-
formed by, or the effect emerged as a consequence of 
saying something.
The perlocutionary/illocutionary distinction has not 
received as much attention in the literature. Nevertheless, 
it seems a critical distinction when adopting a broader 
view of pragmatic interaction, namely not only one that 
pays attention to the linguistic utterances and their struc-
tural configurations but also to the overall communica-
tive picture, including the speaker’s intentions, the effect 
of linguistics interaction on conversational participants, 
and the cognitive and social mechanism underlying 
them. Pragmatic competence includes knowledge about 
the constraints regulating such interaction patterns and, 
as any other type of linguistic competence, it is part of 
the cognitive endowment of human beings (by nature). 
At the same time, it is also subject to evolution, includ-
ing learning at the first stages of life and impairment 
and deterioration associated with the aging process and 
as a byproduct of disease (Perkins 2007). In what fol-
lows we will talk about pragmatic functions (of the illo-
cutionary or perlocutionary type) to refer to the set of 
inferential processes, strategies, arrangements, and con-
straints regulating illocutionary force and perlocutionary 
effects for speakers. These types of pragmatic functions 
can be partly seen as belonging to executive-function 
mechanisms in general. For example, McDonald (1999) 
considers pragmatic inference generation and execu-
tive function as similar processes, given that “increasing 
degrees of impairment in the executive system corre-
spond to greater and greater impairment of inferential 
reasoning”. Additionally, both executive function and 
inference require simultaneous attention and the pro-
cessing of multiple sources of information in parallel. 
Executive function is by definition inextricably associated 
with the various cognitive, linguistic and sensorimotor 
elements in the intrapersonal domain over which it exer-
cises control.
Preservation of pragmatic function
The idea of intra-nasal insulin as a therapy to improve 
the cognitive capacities and quality of life for Alzhei-
mer (AD) sufferers, their caregivers and families has 
been around since 1989. It was first proposed as a non-
invasive intranasal method for bypassing the blood–
brain barrier (BBB) by William H. Frey II and later 
expanded for the specific use of intranasal insulin to 
target the brain to treat Alzheimer’s disease and other 
CNS disorders (Thorne et  al. 1995; Chen et  al. 1998, 
2004). Now, in 2015, as an AD therapy, it is receiv-
ing more scientific and media attention because it has 
been demonstrated to be safe in multiple, double-blind 
clinical studies with minimal side-effects as substan-
tiated by currently available MRI brain imaging data 
and positive cognitive testing results on over 100 AD 
patients published in several peer-reviewed journals 
(Craft et al. 2012:9; Schioth et al. 2012:8; Claxton et al. 
2014). Currently, it is in stage III of FDA review with 
240 patients (The Study of Nasal Insulin in the Fight 
Against Forgetfulness  (SNIF 2015) (www.clinicaltrials.
gov, identifier–NCT01767909).
Memory decline and language impairment are promi-
nent findings in AD (Grand et al. 2011). Yet, as noted, it 
has also been established in multiple, double-blind clin-
ical trials that the administration of intra-nasal insulin 
improves cognition and verbal working memory in Mild 
Cognitive Decline and early AD patients (Shemesh et al. 
2012:374; Claxton et al 2014). Studies of Mild Cognitive 
Decline and AD patients using short-term intra-nasal 
insulin (4  months or less) showed significantly less 
decline in cognition as measured by Voice Onset Time, 
Delayed Story Recall Score, the Dementia Rating Sever-
ity Scale and the ADCS-ADL scale as compared to the 
placebo group (Reger et  al. 2008). Even less relative 
decline was found on the ADAS-cog score relative to the 
placebo group after 3–4  months of intra-nasal insulin 
use (Reger et  al. 2006, 2008; Craft et  al. 2012:31–32). 
Intranasal insulin’s dispersion into the frontal cortex is 
also extremely important for language capacities as it is 
the hypothesized site of verbal working memory in 
humans (Petrides et  al. 1993). Pioneering participant-
observation research, monitoring twenty-two “compas-
sionate usage” Mild Cognitive Impairment and AD 
patients who have been on long-term intra-nasal insulin 
usage (2  years+) have shown marked improvement on 
intra-nasal insulin (Kurve Technology 2013). At base-
line, before intra-nasal insulin treatment began, these 
“compassion usage” patients usually display some symp-
toms of social and linguistic withdrawal, flattening of 
affect and irritability. The return of illocutionary and 
perlocutionary capacity by these AD patients was also 
immediately noticed by the wives and partners (HBO 
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Documentary 2009).1 Thus, the effect even after several 
months on intra-nasal insulin therapy showed evidence 
of significantly improved perlocutionary effects on 
spouses and partners.
The emergence of perlocutionary effects also relates to 
illocutionary capacity: the ability to express and to look for 
an effect of that expression. The effect that a person might 
want to achieve thorough a specific communication inter-
action can include such effects as validating the other’s per-
sons feelings, agreeing with another’s feelings, expressing 
empathy for the other person, expressing solidarity with 
another and/or even to reduce the amount of perceived 
psychic pain caused by a disappointment. Hsieh et  al. 
(2013:180–181) argues that in AD, the ability to perceive 
another person’s emotional state, to respond emotionally 
and to take the perspective of the other has been found to 
decline with progress of the disease, with empathy loss cor-
related with deficits in emotion processing. The aid of rec-
ognizing facial expressions of emotions is assumed to have 
a role in facilitating feelings of empathy (Hsieh 2013:180).
AD represents a loss of pragmatic competence especially 
in the illocutionary and perlocutionary functions associ-
ated with interactive and expressive linguistic domains. 
Intra-nasal insulin treatment seems to preserve or improve 
pragmatic function related to illocutionary force and perlo-
cutionary effect. All these aspects achieve significant prag-
matic effects (strong, positive perlocutionary responses on 
the listeners), thereby reducing the potential social isolation 
of the Mild Cognitive Impairment or AD patient.
Conclusions
Focusing on effects related to pragmatic competence sug-
gests that the term “cognitive impairment” in AD should 
be understood as a term including not just processes and 
domains related mostly to memory (short/long-term 
recall) but also include perception, language, self-aware-
ness and awareness of others. As Geldmacher (2012:128) 
acknowledges, the academic attempt to create a model 
of “cognitive” decline in AD (which subsumes language) 
is ultimately artificial because “parsing cognitive func-
tions into specific domains reflects the conveniences 
of taxonomy and testing rather than physiological real-
ity”. He notes that “intact human cognition is a seamless 
and interdependent whole”. Improvements in pragmatic 
competence can occur with extended intra-nasal insulin 
treatment even if other cognitive capacities such as mem-
ory do not necessarily improve or change.
1 Research on the short-term administration of intra-nasal insulin 
(3–4  months) also suggests that cognitive functions be subsequently 
assessed individually after treatment in addition to examining performance 
on global cognitive indicators (Craft et al 2014:8). This is because different 
areas of the brain appear to have different dose response profiles (Craft et al 
2014:8).
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